Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients
Not yet recruiting
- Conditions
- Alzheimer Disease
- Registration Number
- NCT05672732
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Alzheimer's Disease patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Alzheimer's Disease patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient is at least 50 to 80 years of age
- Participant has a diagnosis of Alzheimer's Disease
- Patient has self-identified as planning to enroll in an interventional clinical trial for Alzheimer's Disease
Exclusion Criteria
- No diagnosis of Alzheimer's Disease confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a Alzheimer's Disease Clinical Trial 3 months Number of patients who remain in Alzheimer's Disease clinical trial until completion 12 months
- Secondary Outcome Measures
Name Time Method